Literature DB >> 21146463

Gray matter volumes of pain-related brain areas are decreased in fibromyalgia syndrome.

Michael E Robinson1, Jason G Craggs, Donald D Price, William M Perlstein, Roland Staud.   

Abstract

UNLABELLED: Fibromyalgia (FM) is a chronic, widespread musculoskeletal pain disorder that is very prevalent in the general population (approximately 5%). Accumulating evidence suggests that FM is associated with central pain processing abnormalities, ie, central sensitization. Several previous studies of chronic pain patients, including FM, have shown gray matter atrophy of brain areas associated with sensory and affective pain processing. These findings, however, have not been confirmed in all FM studies. In this study, we investigated gray matter volumes of brain areas associated with pain-related areas of FM patients identified by functional brain imaging. Using voxel-based morphometric (VBM) analysis of magnetic resonance brain images, we compared 19 pain-related brain areas of 14 female FM patients and 11 healthy controls (NC). We found that FM patients had significantly less gray matter volumes than NC in 3 of these brain regions, including the anterior and mid-cingulate, as well as mid-insular cortices. Importantly, FM patients demonstrated neither global gray matter atrophy nor gray matter changes associated with depression, as shown in some studies. Using a more stringent analysis than other VBM studies, we provide evidence for decreased gray matter volumes in a number of pain-related brain areas in FM. Although the mechanisms for these gray matter changes are presently unclear, they may contribute to some of the core features of this chronic disorder including affective disturbances and chronic widespread pain. PERSPECTIVE: Increasing evidence supports the association of chronic pain with accelerated gray matter atrophy in pain disorders like low back pain, IBS, and FM syndrome. However, cause-effect relationships between chronic pain and decreased gray matter volumes have not been established yet and will require future prospective studies.
Copyright © 2011 American Pain Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21146463      PMCID: PMC3070837          DOI: 10.1016/j.jpain.2010.10.003

Source DB:  PubMed          Journal:  J Pain        ISSN: 1526-5900            Impact factor:   5.820


  50 in total

1.  Brain activity related to temporal summation of C-fiber evoked pain.

Authors:  Roland Staud; Jason G Craggs; Michael E Robinson; William M Perlstein; Donald D Price
Journal:  Pain       Date:  2006-12-06       Impact factor: 6.961

2.  Placebo analgesia is accompanied by large reductions in pain-related brain activity in irritable bowel syndrome patients.

Authors:  Donald D Price; Jason Craggs; G Nicholas Verne; William M Perlstein; Michael E Robinson
Journal:  Pain       Date:  2006-09-08       Impact factor: 6.961

Review 3.  Limbic system mechanisms of stress regulation: hypothalamo-pituitary-adrenocortical axis.

Authors:  James P Herman; Michelle M Ostrander; Nancy K Mueller; Helmer Figueiredo
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2005-11-04       Impact factor: 5.067

4.  Gray matter decrease in patients with chronic tension type headache.

Authors:  T Schmidt-Wilcke; E Leinisch; A Straube; N Kämpfe; B Draganski; H C Diener; U Bogdahn; A May
Journal:  Neurology       Date:  2005-11-08       Impact factor: 9.910

Review 5.  Plasticity in brain processing and modulation of pain.

Authors:  Donald D Price; G Nicholas Verne; Jeffrey M Schwartz
Journal:  Prog Brain Res       Date:  2006       Impact factor: 2.453

6.  Increased muscle pain sensitivity in patients with tension-type headache.

Authors:  Peter T Schmidt-Hansen; Peter Svensson; Lars Bendtsen; Thomas Graven-Nielsen; Flemming W Bach
Journal:  Pain       Date:  2006-12-11       Impact factor: 6.961

7.  Functional brain interactions that serve cognitive-affective processing during pain and placebo analgesia.

Authors:  Jason G Craggs; Donald D Price; G Nicholas Verne; William M Perlstein; Michael M Robinson
Journal:  Neuroimage       Date:  2007-08-16       Impact factor: 6.556

8.  Striatal grey matter increase in patients suffering from fibromyalgia--a voxel-based morphometry study.

Authors:  T Schmidt-Wilcke; R Luerding; T Weigand; T Jürgens; G Schuierer; E Leinisch; U Bogdahn
Journal:  Pain       Date:  2007-06-22       Impact factor: 6.961

9.  Accelerated brain gray matter loss in fibromyalgia patients: premature aging of the brain?

Authors:  Anil Kuchinad; Petra Schweinhardt; David A Seminowicz; Patrick B Wood; Boris A Chizh; M Catherine Bushnell
Journal:  J Neurosci       Date:  2007-04-11       Impact factor: 6.167

Review 10.  Biology and therapy of fibromyalgia. Functional magnetic resonance imaging findings in fibromyalgia.

Authors:  David A Williams; Richard H Gracely
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

View more
  61 in total

1.  Strategy-dependent dissociation of the neural correlates involved in pain modulation.

Authors:  Jane M Lawrence; Fumiko Hoeft; Kristen E Sheau; Sean C Mackey
Journal:  Anesthesiology       Date:  2011-10       Impact factor: 7.892

2.  The development and psychometric validation of the central sensitization inventory.

Authors:  Tom G Mayer; Randy Neblett; Howard Cohen; Krista J Howard; Yun H Choi; Mark J Williams; Yoheli Perez; Robert J Gatchel
Journal:  Pain Pract       Date:  2011-09-27       Impact factor: 3.183

Review 3.  Biomarkers for Musculoskeletal Pain Conditions: Use of Brain Imaging and Machine Learning.

Authors:  Jeff Boissoneault; Landrew Sevel; Janelle Letzen; Michael Robinson; Roland Staud
Journal:  Curr Rheumatol Rep       Date:  2017-01       Impact factor: 4.592

4.  HIV Distal Neuropathic Pain Is Associated with Smaller Ventral Posterior Cingulate Cortex.

Authors:  John R Keltner; Colm G Connolly; Florin Vaida; Mark Jenkinson; Christine Fennema-Notestine; Sarah Archibald; Cherine Akkari; Alexandra Schlein; Jisu Lee; Dongzhe Wang; Sung Kim; Han Li; Austin Rennels; David J Miller; George Kesidis; Donald R Franklin; Chelsea Sanders; Stephanie Corkran; Igor Grant; Gregory G Brown; J Hampton Atkinson; Ronald J Ellis
Journal:  Pain Med       Date:  2017-03-01       Impact factor: 3.750

Review 5.  Sex-based differences in brain alterations across chronic pain conditions.

Authors:  Arpana Gupta; Emeran A Mayer; Connor Fling; Jennifer S Labus; Bruce D Naliboff; Jui-Yang Hong; Lisa A Kilpatrick
Journal:  J Neurosci Res       Date:  2017-01-02       Impact factor: 4.164

6.  Altered Associations between Pain Symptoms and Brain Morphometry in the Pain Matrix of HIV-Seropositive Individuals.

Authors:  Deborrah Castillo; Thomas Ernst; Eric Cunningham; Linda Chang
Journal:  J Neuroimmune Pharmacol       Date:  2017-09-02       Impact factor: 4.147

7.  Brain neuroplastic changes accompany anxiety and memory deficits in a model of complex regional pain syndrome.

Authors:  Maral Tajerian; David Leu; Yani Zou; Peyman Sahbaie; Wenwu Li; Hamda Khan; Vivian Hsu; Wade Kingery; Ting Ting Huang; Lino Becerra; J David Clark
Journal:  Anesthesiology       Date:  2014-10       Impact factor: 7.892

8.  Altered resting state functional connectivity of the cognitive control network in fibromyalgia and the modulation effect of mind-body intervention.

Authors:  Jian Kong; Emily Wolcott; Zengjian Wang; Kristen Jorgenson; William F Harvey; Jing Tao; Ramel Rones; Chenchen Wang
Journal:  Brain Imaging Behav       Date:  2019-04       Impact factor: 3.978

9.  The Central Sensitization Inventory (CSI): establishing clinically significant values for identifying central sensitivity syndromes in an outpatient chronic pain sample.

Authors:  Randy Neblett; Howard Cohen; YunHee Choi; Meredith M Hartzell; Mark Williams; Tom G Mayer; Robert J Gatchel
Journal:  J Pain       Date:  2013-03-13       Impact factor: 5.820

10.  FMRI of spinal and supra-spinal correlates of temporal pain summation in fibromyalgia patients.

Authors:  Rachael L Bosma; Elham Ameli Mojarad; Lawrence Leung; Caroline Pukall; Roland Staud; Patrick W Stroman
Journal:  Hum Brain Mapp       Date:  2016-01-09       Impact factor: 5.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.